all AI news
TAGMol: Target-Aware Gradient-guided Molecule Generation
June 5, 2024, 4:43 a.m. | Vineeth Dorna, D. Subhalingam, Keshav Kolluru, Shreshth Tuli, Mrityunjay Singh, Saurabh Singal, N. M. Anoop Krishnan, Sayan Ranu
cs.LG updates on arXiv.org arxiv.org
Abstract: 3D generative models have shown significant promise in structure-based drug design (SBDD), particularly in discovering ligands tailored to specific target binding sites. Existing algorithms often focus primarily on ligand-target binding, characterized by binding affinity. Moreover, models trained solely on target-ligand distribution may fall short in addressing the broader objectives of drug discovery, such as the development of novel ligands with desired properties like drug-likeness, and synthesizability, underscoring the multifaceted nature of the drug design process. …
abstract algorithms arxiv cs.ai cs.lg design distribution drug design focus generative generative models gradient ligands q-bio.bm type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Senior Data Engineer
@ Displate | Warsaw
Content Designer
@ Glean | Palo Alto, CA
IT&D Data Solution Architect
@ Reckitt | Hyderabad, Telangana, IN, N/A
Python Developer
@ Riskinsight Consulting | Hyderabad, Telangana, India
Technical Lead (Java/Node.js)
@ LivePerson | Hyderabad, Telangana, India (Remote)
Backend Engineer - Senior and Mid-Level - Sydney Hybrid or AU remote
@ Displayr | Sydney, New South Wales, Australia